Drugs / YYC506
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT04874129 | Jan → May 2021 | hyperlipidemia | Yooyoung Pharmaceutical Co., Ltd. | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT04858308 Comparator | Jan → May 2021 | hyperlipidemia | Yooyoung Pharmaceutical Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | YYC506 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04858308 ↗ |